Prevented effect of Ginkgo Biloba extract an liver fibrosis of rat

Hao LIU,Jieping YU,Zhaohong SHI,Song LIU

DOI: https://doi.org/10.3969/j.issn.1006-5709.2005.05.013

2005-01-01

Abstract:Objective To investigate the effects of EGB on hepatic fibros h and expression of TGF-β_1 in rats with cirrhosis. Methods Thirty adult male SD rats randomized into 3 groups: control group (n=10),model group (n=10) and treatment group(n=10). Except the rats of control group, others were inflicted with liver cirrhosis by administration of CCL4 (50%, lml/kg) for 8 weeks. Those rats in the treatment group were intragastrically administered with EGB(0.4g/kg) for 8 weeks. At the end of the 8th week, all rats were sacrificed. Blood samples were collected for determination of ALT, AST and ALB. The area of collagenwas examined by image analyzing system. The expression of TGF-β_1 and α-SMA was deter mined by immunohistochemistry. The expression of TGF-β_1 mRNA was deter mined by RT-PCR. Results The level of ALT, AST and ALB in EGB-treated group were lawerthan that of model group (P0.01). The grade of fibrosis and the area of collagen in EGB-treated group were lower than that of the model group (P0.05). The treatment with EGB significantly reduced mRNA and protein levels of TGF-β_1, and also reduced protein levels of a-SMA. Conclusion EGB can significantly attenuate the degree of hepatic fibrosis.